Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Gregory Reyes is Director at Artelo Biosciences. OQRO lists 2 transactions filed with the SEC under this name, the latest on Jul 21, 2026, each linked to the official Form 4.
Director
Disclosures on record
2
Companies involved
1
Artelo BiosciencesARTL
2 disclosures · Feb 2026 – Jul 2026
Jul 17, 2026136disclosed Jul 21
DetailsOfficial recordJan 30, 2026292disclosed Feb 2
DetailsOfficial recordGregory Reyes bought shares on the open market in 2008, and has not bought since 2008.
In SEC filings since 2008: the latest open-market purchase is from 2008; no open-market sale is on record.
Bio Green Med Solution (BGMS), from 2008 to 2008: 1 purchase and 0 sales.
Gregory Reyes bought shares on the open market in 2008, and has not bought since 2008.
Gregory Reyes reported 1 open-market purchase and 0 sales since 2008; purchases in 2008.
| Year | Bought | Sold |
|---|---|---|
| 2008 | $8.7K1×1 trade | — |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
Gregory Reyes reported 1 open-market purchase and 0 sales here, 2008.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.